• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病早期诊断的研究进展。

Research progress in the early diagnosis of Parkinson's disease.

机构信息

Qingdao University, Qingdao, 266071, Shandong, China.

Weifang Medical University, Weifang, 261053, Shandong, China.

出版信息

Neurol Sci. 2022 Nov;43(11):6225-6231. doi: 10.1007/s10072-022-06316-0. Epub 2022 Aug 11.

DOI:10.1007/s10072-022-06316-0
PMID:35948779
Abstract

Parkinson's disease is the second major neurodegenerative disease with increasing incidence and population in the world year by year. The pathogenesis of Parkinson's disease is still not completely clear, and the identification of Parkinson's disease prodromal manifestations and accurate diagnosis is still facing great challenges. This review summarizes the interaction of environmental toxicants, mitochondrial dysfunction, α-synuclein, gut microbiome dysbiosis, neuroinflammation, and other pathophysiological factors in Parkinson's disease. It also discusses the prodromal manifestations of Parkinson's disease, such as olfactory dysfunction, sleep dysfunction and other non-motor symptoms, the current diagnostic challenges, and the application status of emerging neuroimaging technologies such as magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission tomography (SPECT).

摘要

帕金森病是全球第二大发病率和患病人数逐年增加的神经退行性疾病。帕金森病的发病机制尚不完全清楚,帕金森病前驱期表现的识别和准确诊断仍面临巨大挑战。本文综述了环境毒物、线粒体功能障碍、α-突触核蛋白、肠道微生物组失调、神经炎症等病理生理因素在帕金森病中的相互作用,讨论了帕金森病的前驱期表现,如嗅觉功能障碍、睡眠功能障碍等非运动症状,目前的诊断挑战,以及磁共振成像(MRI)、正电子发射断层扫描(PET)、单光子发射断层扫描(SPECT)等新兴神经影像学技术的应用现状。

相似文献

1
Research progress in the early diagnosis of Parkinson's disease.帕金森病早期诊断的研究进展。
Neurol Sci. 2022 Nov;43(11):6225-6231. doi: 10.1007/s10072-022-06316-0. Epub 2022 Aug 11.
2
Position Emission Tomography/Single-Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease.正电子发射断层扫描/单光子发射计算机断层扫描神经成像用于检测运动前帕金森病
CNS Neurosci Ther. 2016 Mar;22(3):167-77. doi: 10.1111/cns.12493. Epub 2016 Jan 18.
3
The role of neuroimaging in Parkinson's disease.神经影像学在帕金森病中的作用。
J Neurochem. 2021 Nov;159(4):660-689. doi: 10.1111/jnc.15516. Epub 2021 Oct 3.
4
Imaging the Nonmotor Symptoms in Parkinson's Disease.帕金森病非运动症状的影像学检查
Int Rev Neurobiol. 2017;133:179-257. doi: 10.1016/bs.irn.2017.05.001. Epub 2017 Jun 7.
5
Imaging in Parkinson's Disease.帕金森病的影像学
Int Rev Neurobiol. 2017;132:233-274. doi: 10.1016/bs.irn.2017.02.015. Epub 2017 Mar 30.
6
Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease.特发性快速眼动睡眠行为障碍中的基底神经节功能障碍与早期帕金森病中的情况相似。
Brain. 2016 Aug;139(Pt 8):2224-34. doi: 10.1093/brain/aww124. Epub 2016 Jun 12.
7
Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.帕金森病和非典型帕金森综合征的神经影像学进展
Front Neurol. 2020 Oct 15;11:572976. doi: 10.3389/fneur.2020.572976. eCollection 2020.
8
New molecular targets for PET and SPECT imaging in neurodegenerative diseases.用于神经退行性疾病的 PET 和 SPECT 成像的新分子靶标。
Braz J Psychiatry. 2012 Oct;34 Suppl 2:S125-36. doi: 10.1016/j.rbp.2012.07.002.
9
An overview: Radiotracers and nano-radiopharmaceuticals for diagnosis of Parkinson's disease.概述:用于诊断帕金森病的放射性示踪剂和纳米放射性药物。
Appl Radiat Isot. 2024 Jan;203:111110. doi: 10.1016/j.apradiso.2023.111110. Epub 2023 Nov 17.
10
Radiotracers for imaging of Parkinson's disease.用于帕金森病成像的放射性示踪剂。
Eur J Med Chem. 2019 Mar 15;166:75-89. doi: 10.1016/j.ejmech.2019.01.029. Epub 2019 Jan 14.

引用本文的文献

1
Evaluation of non-motor symptoms in Parkinson's disease using multiparametric MRI with the multiplex sequence.使用多重序列的多参数MRI评估帕金森病的非运动症状。
Front Aging Neurosci. 2025 Jul 16;17:1602245. doi: 10.3389/fnagi.2025.1602245. eCollection 2025.
2
Neuroprotective effects and mechanisms of the YiQiWenYangSanHan formula on Parkinson's disease mice.益气温阳散寒方对帕金森病小鼠的神经保护作用及机制
IBRO Neurosci Rep. 2025 Apr 1;18:528-538. doi: 10.1016/j.ibneur.2025.03.014. eCollection 2025 Jun.
3
The Expanding Burden of Neurodegenerative Diseases: An Unmet Medical and Social Need.

本文引用的文献

1
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes.神经丝轻链和α-突触核蛋白实时无细胞扩增检测作为帕金森症及相关综合征的鉴别诊断生物标志物
NPJ Parkinsons Dis. 2021 Oct 11;7(1):93. doi: 10.1038/s41531-021-00232-4.
2
Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder.特发性 REM 睡眠行为障碍患者黑质中自由水增加。
Brain. 2021 Jun 22;144(5):1488-1497. doi: 10.1093/brain/awab039.
3
Parkinson's disease.帕金森病。
神经退行性疾病不断加重的负担:一项未得到满足的医学和社会需求。
Aging Dis. 2024 Nov 9. doi: 10.14336/AD.2024.1071.
4
The value of PET/CT in the diagnosis and differential diagnosis of Parkinson's disease: a dual-tracer study.PET/CT在帕金森病诊断及鉴别诊断中的价值:一项双示踪剂研究。
NPJ Parkinsons Dis. 2024 Sep 10;10(1):171. doi: 10.1038/s41531-024-00786-z.
5
A Review of the Role of Estrogens in Olfaction, Sleep and Glymphatic Functionality in Relation to Sex Disparity in Alzheimer's Disease.雌激素在嗅觉、睡眠及类淋巴功能中的作用与阿尔茨海默病性别差异的综述
Am J Alzheimers Dis Other Demen. 2024 Jan-Dec;39:15333175241272025. doi: 10.1177/15333175241272025.
6
Dietary supplementation of extract alleviates motor deficits in MPTP-induced Parkinson's disease mice and its underlying mechanism.提取物的膳食补充可减轻MPTP诱导的帕金森病小鼠的运动功能障碍及其潜在机制。
Front Nutr. 2023 Feb 14;9:1121789. doi: 10.3389/fnut.2023.1121789. eCollection 2023.
7
Neurons, Nose, and Neurodegenerative Diseases: Olfactory Function and Cognitive Impairment.神经元、鼻子与神经退行性疾病:嗅觉功能与认知障碍。
Int J Mol Sci. 2023 Jan 20;24(3):2117. doi: 10.3390/ijms24032117.
Lancet. 2021 Jun 12;397(10291):2284-2303. doi: 10.1016/S0140-6736(21)00218-X. Epub 2021 Apr 10.
4
Neuroinflammation in Parkinson's Disease: Triggers, Mechanisms, and Immunotherapies.帕金森病中的神经炎症:触发因素、机制和免疫疗法。
Neuroscientist. 2022 Aug;28(4):364-381. doi: 10.1177/1073858421991066. Epub 2021 Feb 12.
5
Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.发展和验证帕金森病自动化影像鉴别(AID-P):一项多中心机器学习研究。
Lancet Digit Health. 2019 Sep;1(5):e222-e231. doi: 10.1016/s2589-7500(19)30105-0. Epub 2019 Aug 27.
6
Diagnosis and Treatment of Parkinson Disease: A Review.帕金森病的诊断与治疗:综述。
JAMA. 2020 Feb 11;323(6):548-560. doi: 10.1001/jama.2019.22360.
7
Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder.特发性快速眼动睡眠行为障碍中铁含量的定量评估。
Mov Disord. 2020 Mar;35(3):478-485. doi: 10.1002/mds.27929. Epub 2019 Dec 17.
8
Using global team science to identify genetic parkinson's disease worldwide.利用全球团队科学在全球范围内识别遗传性帕金森病。
Ann Neurol. 2019 Aug;86(2):153-157. doi: 10.1002/ana.25514. Epub 2019 Jun 26.
9
Serum NFL discriminates Parkinson disease from atypical parkinsonisms.血清 NFL 可区分帕金森病与非典型帕金森综合征。
Neurology. 2019 Mar 26;92(13):e1479-e1486. doi: 10.1212/WNL.0000000000007179. Epub 2019 Feb 27.
10
Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and Parkinson's Disease.利用3T磁共振成像对黑质中黑质小体-1和神经黑色素进行联合可视化以鉴别诊断特发性震颤和帕金森病
Front Neurol. 2019 Feb 12;10:100. doi: 10.3389/fneur.2019.00100. eCollection 2019.